Matinas BioPharma | Investor Presentation Deck | 31 slides · page 25 of 31
The slide demonstrates that oral LNC-docetaxel is as effective as IV docetaxel with no significant side effects.
Pitch deck · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 2/2 chart 1/1 diagram 1/1 title 1/1
Components 5
primary primary line timeline headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1